Carson Wealth (CWM LLC)’s ACELYRIN SLRN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,090	Closed	-$32K	–	5286
2025 Q1	$32K	Buy	13,090 +12,933	+8,238%	+$30.8K	﹤0.01%	3342
2024 Q4	$0	Sell	157 -10	-6%	-$48	﹤0.01%	5139
2024 Q3	$1K	Buy	167 +12	+8%	+$62	﹤0.01%	4707
2024 Q2	$1K	Sell	155 -64	-29%	-$300	﹤0.01%	4481
2024 Q1	$1K	Buy	219 +206	+1,585%	+$1.56K	﹤0.01%	4214
2023 Q4	$0	Buy	+13	New	+$111	﹤0.01%	4487

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s SLRN Position: Q2 2025 in Review

Carson Wealth (CWM LLC) sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 13,090 shares — an estimated $32K sold.

Carson Wealth (CWM LLC) first reported a position in SLRN in Q4 2023 and held it in 6 quarters. The position peaked at $32K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Carson Wealth (CWM LLC) reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 13,090 ACELYRIN shares in Q2 2025, an estimated $32K.
Carson Wealth (CWM LLC) first reported a position in ACELYRIN in Q4 2023 and held it in 6 quarters.
Carson Wealth (CWM LLC)'s ACELYRIN position peaked at $32K in Q1 2025.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2025, filed 25 Jul 2025.